Nov 15 (Reuters) - Masimo Corp , a maker of non-invasive patient monitoring products, told U.S. regulators that it received allegations about the safety and efficacy of its hemoglobin testing products ...
Noting that in this area of care it is “essential to remain informed by the latest evidence,” the ESAIC, which has pledged to revisit its perioperative blood management guidelines at least every five ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto ® Pulse CO-Oximeter ® with Next Generation SpHb ® Spot Check ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results